Characterization of hepatic markers in human Wharton's Jelly-derived mesenchymal stem cells

Toxicology in Vitro

Volumn 28, Issue 1, 2014, Pages 113-119

  Buyl, Karolien ^a   De Kock, Joery ^a   Najar, Mehdi ^b   Lagneaux, Laurence ^b   Branson, Steven ^a   Rogiers, Vera ^a   Vanhaecke, Tamara ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Adult stem cells; Hepatocyte; Liver development; Umbilical cord; Wharton's Jelly

Indexed keywords

ALB PROTEIN; BIOLOGICAL MARKER; CELL MARKER; CX32 PROTEIN; CX43 PROTEIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; DICKKOPF 1 PROTEIN; DPP4 PROTEIN; DSG2 PROTEIN; HNF1A PROTEIN; HNF4A PROTEIN; K18 PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADULT STEM CELL; ARTICLE; CONTROLLED STUDY; HEPATOCYTE LIKE CELL; HUMAN; HUMAN CELL; LIVER CELL; LIVER DEVELOPMENT; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; WHARTON JELLY;

4′,6-DIAMIDINO-2-PHENYLINDOLE; ACTB; ADULT STEM CELLS; AFP; ALB; ALBUMIN; B2M; BETA-2-MICROGLOBULIN; BETA-ACTIN; CONNEXIN; CX; CYP; CYTOCHROME P450; DAPI; DESMOGLEIN; DICKKOPF; DIPEPTIDYL-PEPTIDASE; DKK; DMEM-LG; DPP; DSG; DULBECCO'S MODIFIED EAGLE MEDIUM-LOW GLUCOSE; EGF; EPIDERMAL GROWTH FACTOR; FBS; FETAL BOVINE SERUM; FGF; FIBROBLAST GROWTH FACTOR; FORKHEAD BOX; FOX; GAP JUNCTION; GAPDH; GJ; GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE; HADSCS; HASCS; HBMSCS; HEPATOCYTE; HEPATOCYTE NUCLEAR FACTOR; HEPS; HMBS; HNF; HSKPS; HUMAN ADIPOSE TISSUE-DERIVED STROMAL CELLS; HUMAN ADULT STEM CELLS; HUMAN BONE MARROW-DERIVED STROMAL CELLS; HUMAN HEPATOCYTES; HUMAN SKIN-DERIVED PRECURSOR CELLS; HUMAN WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS; HWJS; HYDROXY-METHYLBILANE SYNTHASE; K; KERATIN; KRT; LIVER DEVELOPMENT; MESENCHYMAL STEM CELLS; MSCS; ND; NOT SIGNIFICANTLY DETECTED; ONECUT; ONECUT HOMEOBOX; PARAFORMALDEHYDE; PBS; PFA; PHOSPHATE BUFFERED SALINE; QPCR; QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX DETERMINING REGION Y-BOX; SOX; UBC; UBIQUITIN C; UMBILICAL CORD; WHARTON'S JELLY; Α-FOETOPROTEIN;

ADULT; BIOLOGICAL MARKERS; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; HUMANS; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; RNA, MESSENGER; TOXICITY TESTS; TRANSCRIPTION FACTORS; WHARTON JELLY;

EID: 84888287986     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.06.014     Document Type: Article

References (30)

1. Antoniou A., Raynaud P., Cordi S., Zong Y., Tronch F., Stanger B.Z., Jacquemin P., Pierreux C.E., Clotman F., Lemaigre F.P. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroeneterology 2009, 136:2325-2333.
2. Anzalone R., Lo Iacono M., Corrao S., Magno F., Loria T., Cappello F., Zummo G., Farina F., La Rocca G. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev. 2010, 19:423-438.
3. Aurich H., Sgodda M., Kaltwasser P., Vetter M., Weise A., Liehr T., Brulport M., Hengstler J.G., Dollinger M.M., Fleig W.E., Christ B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009, 58:570-581.
4. Baranczewski P., Stanczak A., Sundberg K., Svensson R., Wallin A., Jansson J., Garberg P., Postlind H. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 2006, 58:453-472.
5. Bossard P., Zaret K.S. GATA transcription factors as potentiators of gut endoderm differentiation. Development 1998, 125:4909-4917.
6. Campard D., Lysy P.A., Najimi M., Sokal E.M. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008, 134:833-848.
7. Costello I., Biondi C.A., Taylor J.M., Bikoff E.K., Robertson E.J. Smad4-dependent pathways control basement membrane deposition and endodermal cell migration at early stages of mouse development. BMC Dev. Biol. 2009, 9:54.
8. De Bruyn C., Najar M., Raicevic G., Meuleman N., Pieter K., Stamatopoulos B., Delforge A., Bron D., Lagneaux L. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev. 2011, 20:547-557.
9. De Kock J., Vanhaecke T., Biernaskie J., Rogiers V., Snykers S. Characterization and hepatic differentiation of skin-derived precursors from adult foreskin by sequential exposure to hepatogenic cytokines and growth factors reflecting liver development. Toxicol. In Vitro 2009, 23:1522-1527.
10. De Kock J., Najar M., Bolleyn J., Al Battah F., Rodrigues R.M., Buyl K., Raicevic G., Govaere O., Branson S., Meganathan K., Gaspar J.A., Roskams T., Sachinidis A., Lagneaux L., Vanhaecke T., Rogiers V. Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential. Stem Cells Dev. 2012, 21:3309-3323.
11. Duncan S.A. Mechanisms controlling early development of the liver. Mech. Dev. 2003, 120:19-33.
12. Gago N., Perez-Lopez V., Pablo Sanz-Jaka J., Cormenzana P., Eizaguirre I., Bernad A., Izaeta A. Age-dependent depletion of human skin-derived progenitor cells. Stem Cells 2009, 27:1164-1172.
13. Gómez-Lechón M.J., Donato M.T., Castell J.V., Jover R. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man. Curr. Drug Metab. 2004, 5:443-462.
14. Kaestner K.H. The making of the liver - developmental competence in foregut endoderm and induction of the hepatogenic program. Cell Cycle 2005, 4:1146-1148.
15. Leeb C., Jurga M., McGuckin C., Forraz N., Thallinger C., Morrigl L., Kenner L. New perspectives in stem cell research: beyond embryonic stem cells. Cell Prolif. 2011, 44:9-14.
16. Mandenius C.F., Andersson T.B., Alves P.M., Batzl-Hartmann C., Björquist P., Carrondo M.J., Chesne C., Coecke S., Edsbagge J., Fredriksson J.M., Gerlach J.C., Heinzle E., Ingelman-Sundberg M., Johansson I., Küppers-Munther B., Müller-Vieira U., Noor F., Zeilinger K. Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project. Altern. Lab. Anim. 2011, 39:147-171.
17. Margagliotti S., Clotman F., Pierreux C.E., Beaudry J.B., Jacquemin P., Rousseau G.G., Lemaigre F.P. The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev. Biol. 2007, 311:579-589.
18. Meng Q. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 2010, 6:733-746.
19. Nava P., Laukoetter M.G., Hopkins A.M., Laur O., Gerner-Smidt K., Green K.J., Parkos C.A., Nusrat A. Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium. Mol. Biol. Cell. 2007, 18:4565-4578.
20. Okada K., Kamiya A., Ito K., Yanagida A., Ito H., Kondou H., Nishina H., Nakauchi H. Prospective isolation and characterization of bipotent progenitor cells in early mouse liver development. Stem Cells Dev. 2011, 21:1124-1133.
21. Park J.E., Kim H.T., Lee S., Lee Y.S., Choi U.K., Kang J.H., Choi S.Y., Kang T.C., Choi M.S., Kwon O.S. Differential expression of intermediate filaments in the process of developing hepatic steatosis. Proteomics 2011, 11:2777-2789.
22. Parviz F., Matullo C., Garrison W.D., Savatski L., Adamson J.W., Ning G., Kaestner K.H., Rossi J.M., Zaret K.S., Duncan S.A. Hepatocyte nuclear factor 4 alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat. Genet. 2003, 34:292-296.
23. Sato N., Yamabuki T., Takano A., Koinuma J., Aragaki M., Masuda K., Ishikawa N., Kohno N., Ito H., Miyamoto M., Nakayama H., Miyagi Y., Tsuchiya E., Kondo S., Nakamura Y., Daigo Y. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010, 70:5326-5336.
24. Si-Tayeb K., Lemaigre F.P., Duncan S.A. Organogenesis and development of the liver. Dev. Cell. 2010, 18:175-189.
25. Snykers S., Vanhaecke T., De Becker A., Papeleu P., Vinken M., Van Riet I., Rogiers V. Chromatin remodeling agent trichostatin a: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. BMC Dev. Biol. 2007, 7:24.
26. Spee B., Carpino G., Schotanus B.A., Katoonizadeh A., Vander Borght S., Gaudio E., Roskams T. Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 2010, 59(2):247-257.
27. Toma J.G., Akhavan M., Fernandes K.J., Barnabé-Heider F., Sadikot A., Kaplan D.R., Miller F.D. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell. Biol. 2001, 3:778-784.
28. Vinken M., Decrock E., Vanhaecke T., Leybaert L., Rogiers V. Connexin43 signaling contributes to spontaneous apoptosis in cultures of primary hepatocytes. Toxicol. Sci. 2012, 125:175-186.
29. Yoon H.-H., Jung B.-Y., Seo Y.-K., Song K.-Y., Park J.-K. In vitro hepatic differentiation of umbilical cord-derived mesenchymal stem cell. Process Biochem. 2010, 45:1857-1864.
30. Zhang Y.N., Lie P.C., Wei X. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cythotherapy 2009, 11:548-558.